Transforming growth factor β1 induces the expression of α1(I) procollagen mRNA by a hydrogen peroxide-C/EBPβ-dependent mechanism in rat hepatic stellate cells

Hepatology

Volumn 29, Issue 3, 1999, Pages 960-970

  García Trevijano, Elena R ^a,c   Iraburu, Maria J ^a,c   Fontana, Luis ^a,d   Domínguez Rosales, José A ^a   Auster, Anitra ^a   Covarrubias Pinedo, Amador ^a   Rojkind, Marcos ^a,b  

^a MARION BESSIN LIVER RESEARCH CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

^d Facultad de Farmacia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; HYDROGEN PEROXIDE; MESSENGER RNA; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; LIVER CELL; LIVER FIBROSIS; NONHUMAN; NORTHERN BLOTTING; OXIDATIVE STRESS; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; RAT; RECEPTOR UPREGULATION; STELLATE CELL;

EID: 0033053458     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290346     Document Type: Article

References (17)

1. Pinzani M. Novel insights into the biology of the Ito cell. Pharmacol Ther 1995:66:387-412.
2. Gressner AM. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int Suppl 1996;54:S39-S45.
3. Bedossa P, Paradis V. Transforming growth factor-β (TGF-β): a key role in liver fibrogenesis. J Hepatol 1995;22:37-42.
4. Massague J. The transforming growth factor beta family. Annu Rev Cell Biol 1990;6:597-641.
5. 2 and phosphorylation of 30 kilodalton proteins as early responses of cell cycle-dependent inhibition of DNA synthesis by transforming growth factor betal. Cell Growth Differ 1991;2:583-591.
6. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139:1221-1229.
7. Castilla A, Prieto J, Fausto N. Transforming growth factor betal and alpha in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991:324:933-940.
8. Annoni G, Weiner FR, Zern MA. Increased transforming growth factor-beta 1 gene expression in human liver disease. J Hepatol 1992;14: 259-264.
9. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 1995:92:2572-2576.
10. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease Prog Liver Dis 1996:14:131-159.
11. Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. J Biol Chem 1989;86:1991-1998.
12. Kamimura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxidation with liver fibrogenesis. HEPATOLOGY 1992;16:448-453.
13. Pietrangelo A. Iron, oxidative stress and liver fibrosis. J Hepatol 1998;28:8-13.
14. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Gentilini G, et al. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 1993;194:1044-1050.
15. Yao T, Esposti SD, Huang L, Arnon R, Spangenberger A, Zern MA. Inhibition of carbontetrachloride-induced liver injury by liposomes containing vitamin E. Am J Physiol 1994;267:G476-G484.
16. Mochida S, Arai M, Ohno A, Maaki N, Ogata I, Fujiwara K. Oxidative stress in hepatocytes and stimulatory state of Kupffer cells after reperfusion differ between warm and cold ischemia in rats. Liver 1994:14:234-240.
17. Laskin DL, Robertson FM, Pilaro AM, Laskin JD. Activation of liver macrophages following phenobarbital treatment of rats. HEPATOLOGY 1988;8:1051-1055.